Nav: Home

Vermont Vaccine Testing Center study reveals effective, single-dose dengue vaccine

March 16, 2016

Researchers at the University of Vermont (UVM) Vaccine Testing Center, along with collaborators at the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health and Johns Hopkins Bloomberg School of Public Health, have been working since 2008 to develop a dengue vaccine that will protect against all four dengue strains. The team's latest research, published today in Science Translational Medicine, reports promising results from clinical trials on a new vaccine that is very effective at preventing dengue infection and is likely to require only a single dose.

The World Health Organization has made the development and introduction of dengue vaccines a high priority. Approximately 40 percent of the world's population - 2.5 billion people - are at risk of contracting dengue, a viral infection spread by mosquitos in tropical and subtropical regions of the world. Dengue fever is best known for producing a high fever, rash and joint pain, but may also cause very serious disease, including hemorrhage and shock, as well as death. Development of vaccines for dengue has been complicated, since disease can be caused by any of four dengue virus serotypes and the vaccine must be tetravalent, providing equal protection against all four serotypes.

The NIH dengue vaccine was designed by Stephen Whitehead, Ph.D., a senior scientist and virologist at the Laboratory of Infectious Diseases at the NIAID. Clinical research was performed at both UVM and Johns Hopkins, where testing was led by Associate Professor Anna Durbin, M.D., corresponding author on the paper. Study volunteers were given vaccine or placebo and were tested for protection against a weakened strain of dengue that causes infection, but no or minimal symptoms. Results demonstrated that all vaccinees were protected from the "challenge" virus, but none of the volunteers receiving placebo vaccines were protected. The vaccine was well-tolerated in all volunteers.

"This work used a robust method which predicts a high likelihood of success for this critically important dengue vaccine," says UVM Professor of Medicine and Vaccine Testing Center Director Beth Kirkpatrick, M.D., who is first author on the paper. "I thank all members of the UVM, Johns Hopkins, and NIH dengue teams who have worked extremely hard over many years to develop this vaccine."

"The NIH dengue vaccine will now proceed to the ultimate test of effectiveness: large field-based trials in dengue-endemic countries," says Kristen Pierce, M.D., associate professor of medicine and UVM clinical investigator. "Beginning later this month, our team will be testing this vaccine in Dhaka, Bangladesh, and a large phase III efficacy trial has already begun in Brazil."

University of Vermont

Related Infectious Diseases Articles:

Critical gaps in our knowledge of where infectious diseases occur
Today Scientists have called for action. The scientific journal Nature Ecology & Evolution have published a joint statement from scientists at Center for Macroecology, Evolution and Climate, University of Copenhagen and North Carolina State University.
'Flying syringes' could detect emerging infectious diseases
Blood-sucking flies can act as 'flying syringes' to detect emerging infectious diseases in wild animals before they spread to humans, according to research published in the journal eLife.
27th European Congress of Clinical Microbiology & Infectious Diseases
Media can register now for the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Vienna, Saturday 22 April to Tuesday 25 April 2017.
Young doctors working in infectious diseases suffering burnout and bullying
One in five physicians working in medical microbiology and infectious diseases is suffering from burnout, bullying and poor work-life balance.
Gut cells are gatekeepers of infectious brain diseases, study finds
Fresh insights into infectious brain conditions help to explain why some people -- and animals -- are more at risk than others.
More than 3 million children under 5 years old will die from infectious diseases next year
A new report outlines the alarming burden of pediatric infectious diseases across the world.
New global migration mapping to help fight against infectious diseases
Geographers at the University of Southampton have completed a large scale data and mapping project to track the flow of internal human migration in low and middle income countries.
More research is needed on how climate change affects infectious diseases
It is time we act proactively to minimize the effect of climate change on our health, say the researchers behind a new review published in Environment International.
A global early warning system for infectious diseases
In the recent issue of EMBO reports, Barbara Han of the Cary Institute of Ecosystem Studies and John Drake of the University of Georgia Odum School of Ecology call for the creation of a global early warning system for infectious diseases.
Ways of reducing the transmission of infectious diseases in transport hubs
Transport plays a major role in the spread of transmissible diseases.

Related Infectious Diseases Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#532 A Class Conversation
This week we take a look at the sociology of class. What factors create and impact class? How do we try and study it? How does class play out differently in different countries like the US and the UK? How does it impact the political system? We talk with Daniel Laurison, Assistant Professor of Sociology at Swarthmore College and coauthor of the book "The Class Ceiling: Why it Pays to be Privileged", about class and its impacts on people and our systems.